Seasonal Allergic Rhinitis
📧 Sign up to get email alerts when something new happens for Seasonal Allergic Rhinitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2009-11-19Clinical Trial Update: Study of Nasonex in the Relief of Nasal Congestion in Patients With Seasonal Allergic Rhinitis (Study P05528)(COMPLETED) [Phase 3]
Phase 3 trial completion update for Nasonex (mometasone furoate) evaluating relief of nasal congestion in seasonal allergic rhinitis; result…
-
CLINICAL_TRIALS trial_result · 2009-11-17Clinical Trial Update: A Study Evaluating the Efficacy and Impact on Health-related Quality of Life of Levocetirizine in Adults With Seasonal Allergic Rhinitis [Phase 4]
A Phase 4 clinical trial evaluating the efficacy and health-related quality of life impact of levocetirizine in adults with seasonal allergi…
-
CLINICAL_TRIALS trial_result · 2009-10-27Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of Two Nasal Sprays to Treat Seasonal Allergies [Phase 3]
A Phase 3 clinical trial evaluated the safety and efficacy of two nasal sprays for seasonal allergic rhinitis; results have been posted.
-
CLINICAL_TRIALS trial_result · 2009-09-30Clinical Trial Update: A Study Comparing the Bioequivalence of Triamcinolone Acetonide Aqueous Nasal Spray (Apotex, Inc.) to That of Nasacort® AQ Nasal Spray (Sanofi-Aventis Pharmaceutical Products, Inc.) In the Treatment of Seasonal Allergic Rhinitis [Phase 3]
Phase 3 trial comparing the bioequivalence of Triamcinolone Acetonide Aqueous Nasal Spray (Apotex) to Nasacort AQ Nasal Spray (Sanofi) for s…
-
FDA approval · 2009-08-19FDA Approved: SINGULAIR — Supplemental Application (Organon LLC)
FDA approved a Supplemental Application for Singulair (montelukast sodium) submitted by Organon LLC. This action typically results in labeli…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2009-08-06Clinical Trial Update: A Study Evaluating the Efficacy and Impact on Health-related Quality of Life of Levocetirizine in Adults With Seasonal Allergic Rhinitis [Phase 4]
Phase 4 trial evaluating levocetirizine for efficacy and health-related quality of life in adults with seasonal allergic rhinitis has comple…
-
CLINICAL_TRIALS trial_result · 2009-07-08Clinical Trial Update: Study of Mometasone Furoate Nasal Spray and Oxymetazoline Nasal Spray Given Together Once A Day To Treat Seasonal Allergic Rhinitis (P04500) [Phase 2]
A Phase 2 trial evaluated once-daily combination therapy with mometasone furoate nasal spray and oxymetazoline nasal spray for seasonal alle…
-
FDA approval · 2009-04-30FDA Approved: AZELASTINE HYDROCHLORIDE — Original Application (Apotex Corp.)
FDA approved Apotex Corp.'s original application for azelastine hydrochloride, a generic antihistamine product.
-
CLINICAL_TRIALS trial_result · 2009-04-29Clinical Trial Update: Safety and Tolerability Study of rBet v1 SLIT Tablets [Phase 1]
Phase 1 safety and tolerability study of recombinant Bet v 1 sublingual immunotherapy tablets (rBet v1 SLIT) in individuals with birch polle…
-
CLINICAL_TRIALS trial_result · 2009-03-20Clinical Trial Update: Fluticasone Furoate Nasal Spray Versus Oral Fexofenadine [Phase 4]
Phase 4 trial comparing intranasal fluticasone furoate to oral fexofenadine in seasonal allergic rhinitis has completed. Results were posted…
-
CLINICAL_TRIALS trial_result · 2009-03-06Clinical Trial Update: Study for the Treatment of Intermittent Allergic Rhinitis With Desloratadine (Study P04683) [Phase 3]
Phase 3 trial evaluating desloratadine for intermittent allergic rhinitis completed with results posted in 2009.
-
FDA label_change · 2009-01-27FDA Approved: SINGULAIR — Supplemental Application (Organon LLC)
FDA approved a supplemental application to update the labeling for Singulair (montelukast) under Organon LLC.
-
CLINICAL_TRIALS trial_result · 2008-09-26Clinical Trial Update: Effect of Intranasal Corticosteroids on Systemic Allergen Specific IgE [NA]
This completed trial examined whether intranasal corticosteroids affect systemic allergen-specific IgE in seasonal allergic rhinitis.
-
CLINICAL_TRIALS trial_result · 2008-09-03Clinical Trial Update: Probiotics for Birch Pollen Allergy [Phase 1, Phase 2]
The document notes the completion of Phase 1 and Phase 2 trials evaluating probiotics for birch pollen–related seasonal allergic rhinitis, s…
-
FDA approval · 2008-06-20FDA Approved: CETIRIZINE HYDROCHLORIDE — Original Application (Sun Pharmaceutical Industries, Inc.)
FDA approved Sun Pharmaceutical's cetirizine hydrochloride under an original generic application, enabling a generic cetirizine hydrochlorid…
-
CLINICAL_TRIALS trial_result · 2008-06-17Clinical Trial Update: Effect of a Nasal Bolus Allergen Challenge on Inflammatory Markers [Phase 1]
Pfizer-conducted Phase 1 trial evaluating the effect of a nasal bolus allergen challenge on inflammatory markers in seasonal allergic rhinit…
-
FDA approval · 2008-04-21FDA Approved: SINGULAIR — Supplemental Application (Organon LLC)
The FDA approved a supplemental application for Singulair (montelukast sodium) submitted by Organon LLC.
-
CLINICAL_TRIALS trial_result · 2008-04-15Clinical Trial Update: Seasonal Allergic Rhinitis and Driving Ability [Phase 4]
A Phase 4 clinical trial assessing the impact of seasonal allergic rhinitis on driving ability has been terminated.
-
FDA approval · 2008-03-07FDA Approved: SINGULAIR — Supplemental Application (Organon LLC)
FDA approved a supplemental application for Singulair (montelukast) by Organon LLC. The action updates labeling under NDA020829.
-
FDA approval · 2007-11-21FDA Approved: OMNARIS — Supplemental Application (Covis Pharma US, Inc)
The FDA approved a supplemental application for Omnaris (ciclesonide) submitted by Covis Pharma US, Inc., authorizing an update to the produ…
-
CLINICAL_TRIALS trial_result · 2007-11-19Clinical Trial Update: Effects of Imatinib in Subjects With Seasonal Allergic Rhinitis and Who Are Sensitive to Timothy Grass Pollen [Phase 1, Phase 2]
Phase 1/2 clinical trials evaluated the safety and potential efficacy of imatinib in subjects with seasonal allergic rhinitis sensitive to T…
-
CLINICAL_TRIALS trial_result · 2007-11-16Clinical Trial Update: Montelukast as a Controller of Atopic Syndrome [Phase 4]
Phase 4 clinical trial evaluating montelukast for control of atopic syndrome has completed, studying its effects in seasonal allergic rhinit…
-
FDA approval · 2007-09-19FDA Approved: GOOD NEIGHBOR PHARMACY CHILDRENS LORATADINE — Supplemental Application (AmerisourceBergen)
The FDA approved a supplemental application for Good Neighbor Pharmacy Children's Loratadine (loratadine) sponsored by AmerisourceBergen.
-
FDA approval · 2007-07-26FDA Approved: CHILDRENS ALLEGRA ALLERGY — Original Application (Chattem, Inc.)
FDA approved the original application for CHILDRENS ALLEGRA ALLERGY (fexofenadine hydrochloride) by Chattem, Inc., establishing its pediatri…
-
FDA approval · 2007-07-19FDA Approved: CLARINEX-D 12 HOUR — Supplemental Application (Organon LLC)
The FDA approved a supplemental application for CLARINEX-D 12 HOUR, a combination product of desloratadine and pseudoephedrine sulfate from …